Cardiovascular Safety Profiles of Aromatase Inhibitors

This publication has 46 references indexed in Scilit:

• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
  New England Journal of Medicine, 2004
• An open randomised trial of second-line endocrine therapy in advanced breast cancer
  European Journal Of Cancer, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Effect of letrozole on the lipid profile in postmenopausal women with breast cancer
  European Journal Of Cancer, 2001
• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients
  European Journal Of Cancer, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Cancer and venous thromboembolism
  American Heart Journal, 1996
• The Inhibition of Coronary Atherosclerosis by Estrogens in Cholesterol-Fed Chicks
  Circulation, 1952